At 13:29 hours, S&P BSE Healthcare index, the largest gainer among sectoral indices, was up 1% or 113 points as compared to 0.40% or 114 points decline in the benchmark S&P BSE Sensex.
SPARC has surged 10% to Rs 200 after the company announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter to its New Drug Application (NDA) for Latanoprost BAK-free eyedrops.
The stock hit a high of Rs 209 in early morning deals and has seen over ten-fold jump in trading volumes. A combined 4.57 million shares representing 2% of total equity of the company changed hands so far.
Wockhardt rallied over 8% to Rs 929, on back of three-fold rise in trading volumes on BSE. The stock hit a 52-week high of Rs 939 in intra-day trade and has seen a combined 4.55 million shares changing hands on the counter on NSE and BSE.
The stock gained 12% in past three trading sessions from Rs 828 after the NSE included the company in its futures & options (F&O) segment from November 28.
Among the other individual stocks, GlaxoSmithKline Pharmaceuticals has surged 7% to Rs 3,180, followed by Indoco Remedies and Natco Pharma, which are up 5% each at Rs 308 and Rs 1,409 respectively.
Aurobindo Pharma, Torrent Pharmaceuticals, Cadila Healthcare, Glenmark Pharmaceuticals, Biocon, Strides Arcolab, Ipca Laboratories and Ranbaxy Laboratories up 1-3%.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)